Brain Signal Training to Enhance Affect Down-regulation — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Germany
University clinic Freiburg, Freiburg im Breisgau University clinic Giessen, Giessen University Clinic Halle (Saale), Halle University Medical Center Hamburg-Eppendorf, Hamburg Central Institute of Mental Health, Mannheim University Clinic Tuebingen, Tübingen Age range
18 Years – 65 Years
Last updated February 2026